Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EpizymeRx
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EpizymeRx
-
Today and every day, we stand with those diagnosed with
#cancer. Your resilience in the face of a devastating diagnosis motivates us as we aim to rewrite treatment for cancer.#RewritingTreatment#WorldCancerDay
#IAmAndIWill
pic.twitter.com/NpiddO9e7uHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#DYK that over 300 million people worldwide are living with a#RareDisease?#RareDiseaseDay is next month on Feb. 29. Join the conversation to raise awareness and show solidarity with those living with rare diseases.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Breaking:@US_FDA grants accelerated approval to $EPZM’s first#oncology product. Read more: https://bwnews.pr/37pc6u3 pic.twitter.com/msOg4q3IOB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As we begin a new year, our vision to rewrite treatment for
#cancer and other serious diseases remains unchanged. Read more about our Vision here: http://epizyme.com/our-vision/#RewritingTreatment#EpinnovationHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read today's announcement:http://www.businesswire.com/news/home/20200106005309/en/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Happy New Year from Epizyme! Our New Year's resolution is to achieve our goals set forth in our Vision 2020. What's yours?pic.twitter.com/tr8W8OYW0c
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#EpiCrew is ready to relax and spend time with family and loved ones for the winter holidays. We're wishing everyone happy holidays, and we'll see you in the New Year!pic.twitter.com/clbbzFMEA2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today
$EPZM announced the submission of its second New Drug Application to the US FDA. Read the announcement: http://bit.ly/2Z31Iol pic.twitter.com/hO0kMEfJe0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Epizyme Announces Unanimous Positive Vote (11-0) from the FDA Oncology Drug Advisory Committee. Read today’s news: http://bit.ly/2PC5m5D pic.twitter.com/1WGVxZfSzL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
A
#pathologist studies biopsies (a small sample of tissue) in a lab & plays a critical role in diagnosing#EpithelioidSarcoma. You might never meet your pathologist, but they play an important role in your care.#ESsentials4ES http://ESsentialsForES.com/epithelioid-sarcoma-care-team/ …pic.twitter.com/La4IfHs6TW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today we announced updated
#FollicularLymphoma data at#ASH19. Read more: http://bit.ly/EPZMASH pic.twitter.com/xvQNTgsKgP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#EpiCrew is Orlando-bound! If you'll be at#ASH19, come visit us at booth #769.pic.twitter.com/MvxrrECP2Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Eating, spending time with family, and maybe watching a little football are all just a few reasons our Epizymers love Thanksgiving. We hope you have a relaxing holiday with the ones you love. Happy Thanksgiving from all of us at Epizyme!pic.twitter.com/IyrAXSDz1b
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@theNCI defines a#rarecancer as one that occurs in fewer than 15 people per 100,000.#EpithelioidSarcoma is rare, with approx. 150-200 people diagnosed with ES in the U.S. per year. (For those who took our quiz: the answer was B!)Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Quiz time!
#EpithelioidSarcoma is a#rarecancer, but do you know how many diagnoses (per 100,000 people) designate a cancer as rare?Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This week, we're joining other
#sarcoma specialists and researchers from around the world in Tokyo at the@ctosociety Annual Meeting.#ctos2019pic.twitter.com/WfXxUazLgi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Receiving an accurate
#diagnosis is the first step in addressing#EpithelioidSarcoma. Because ES is ultra-rare, it can be difficult to diagnose. Learn more: http://ESsentialsforES.com/about-epithelioid-sarcoma/ …#ESsentials4ESpic.twitter.com/1PucKsGOLw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A diagnosis of epithelioid sarcoma can be overwhelming. One helpful resource for your patients that can organize their thoughts and start the conversation is the Medical Appointment Discussion Guide, available here: http://ESsentialsforES.com/epithelioid-sarcoma-support/ …
#ESsentials4ESHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.